media

media

2021-02-18 // Adjuvant Capital Raises $300 Million Global-Health Venture Fund

Go to Article

2021-02-18 // VC style returns on ‘unsexy’ public health bets? Gates-backed Adjuvant Capital gathers $300M to mend a ‘failure of imagination’

Go to Article

2021-02-18 // Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases

Go to Article

2021-02-18 // Public Health-focused Adjuvant Capital, Backed by Merck & Gates, Raises $300m

Go to Article

2021-02-18 // Investors put $300 million into Adjuvant Capital as global health innovation shines

Go to Article

2021-02-18 // New $300 Million Venture Fund Spotlights Role Of Women In Venture Capital And Public Health

Go to Article